Karen Slattery
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Metabolic tracing reveals IL-2 driven glutaminolysis and de novo pyrimidine synthesis in human natural killer cells.
Journal: The Journal of biological chemistry
Published: November 03, 2025
Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer.
Journal: Science immunology
Published: May 09, 2025
La dolce vita: fueling chimeric antigen receptor (CAR) T cells with Glut1 to improve therapeutic efficacy.
Journal: Immunometabolism (Cobham, Surrey)
Published: December 05, 2024
Unveiling the epigenomic mechanisms of acquired platinum-resistance in high-grade serous ovarian cancer.
Journal: International journal of cancer
Published: August 30, 2022
Heightened metabolic responses in NK cells from patients with neuroblastoma suggests increased potential for immunotherapy.
Journal: Frontiers in oncology
Published: July 27, 2022
γδ T cell dichotomy with opposing cytotoxic and wound healing functions in human solid tumors.
Journal: Nature cancer
Published: July 08, 2022
TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer.
Journal: Journal for immunotherapy of cancer
Published: December 23, 2020
NK Cell Metabolism and TGFβ - Implications for Immunotherapy.
Journal: Frontiers in immunology
Published: October 04, 2019
The XIAP inhibitor embelin sensitises malignant rhabdoid tumour cells to TRAIL treatment via enhanced activation of the extrinsic apoptotic pathway.
Journal: International journal of oncology
Published: August 20, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026